Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell|July 25, 2020
SnapShot: Influenza by the NumbersTal Einav, Lauren E Gentles, Jesse D Bloom
Viruses|June 4, 2020
Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor BindingLauren E Gentles, Hongquan Wan, Maryna C Eichelberger, et al.
Viruses|September 9, 2020
Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in MiceAndrea N Loes, Lauren E Gentles, Allison J Greaney, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in miceAndrea N Loes, Lauren E Gentles, Allison J Greaney, et al.
Poultry Science|May 21, 2013
Establishment of an immortal chicken embryo liver-derived cell lineJeongyoon Lee, Douglas N Foster, Walter G Bottje, et al.
Poultry Science|February 26, 2013
Microarray analysis of early and late passage chicken embryo fibroblast cellsByung-Whi Kong, Jeongyoon Lee, Walter G Bottje, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBDAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Science Translational Medicine|June 9, 2021
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infectionAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Plos Pathogens|June 21, 2018
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costsIvan Kosik, William L Ince, Lauren E Gentles, et al.
Plos Pathogens|January 19, 2018
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costsIvan Kosik, William L Ince, Lauren E Gentles, et al.
Pageof 2